[Enhancement of treatment efficacy in experimental plague by the sequential administration of antibiotics]
Abstract:
It was shown that the use of ampicillin, azlocillin or polymyxin 24 or 96 hours after the plague infection at the background of the every-day use of rifampicin in the doses protecting only 30 per cent of the animals from death provided 80-100-percent survival of the animals. With the every-day use of ampicillin, azlocillin or polymyxin in succession with rifampicin there was observed a 3-fold increases in the survival of the albino mice as compared to those exposed to an analogous dose of rifampicin alone. A decrease in the number of administrations of the above drugs and an increase in the intervals between the administration also resulted in a significant rise of the animal survival in comparison with that after the every-day use of a similar dose of rifampicin.
Insights
Combining rifampicin with ampicillin, azlocillin, or polymyxin significantly improved plague survival in mice. Delayed administration and reduced frequency of these antibiotics further enhanced survival rates compared to rifampicin alone.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Plague remains a significant public health concern, necessitating effective therapeutic strategies.
- Rifampicin monotherapy at sub-optimal doses offers limited protection against plague.
- Combination therapy may overcome antibiotic resistance and improve treatment outcomes.
Purpose of the Study:
- To evaluate the efficacy of combination antibiotic therapy for plague treatment.
- To assess the impact of delayed administration and reduced dosing frequency on survival rates.
Main Methods:
- Murine model of plague infection.
- Administration of rifampicin alone or in combination with ampicillin, azlocillin, or polymyxin.
- Varying the timing and frequency of antibiotic administration.
Main Results:
- Combination therapy with ampicillin, azlocillin, or polymyxin, initiated 24 or 96 hours post-infection alongside daily rifampicin, resulted in 80-100% animal survival.
- Sequential administration of ampicillin, azlocillin, or polymyxin with rifampicin led to a threefold increase in survival compared to rifampicin alone.
- Decreased administration frequency and increased intervals between doses of the combination drugs significantly improved survival rates.
Conclusions:
- Combination antibiotic therapy demonstrates superior efficacy in treating plague compared to rifampicin monotherapy.
- Optimizing the dosing schedule of combination therapy can further enhance survival outcomes in plague treatment.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Antibiotic Selection
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Antimicrobial Effectiveness
Plague
Clinical Significance of Antibiotic Resistance
